Inflammatory Bowel Disease Registry in Daegu-Gyeongbuk
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorKyungpook National University Hospital
About this trial
The purpose of this study is to investigate the incidence and natural course of inflammatory bowel disease in the southeastern area of Korea.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Clinical diagnosis of inflammatory bowel disease including Crohn's disease and ulcerative colitis
Followed up for at least 6 months for the correct diagnosis
Disqualifiers
Patients who do not live in Daegu-Gyeongbuk province
Trial population
All patients with inflammatory bowel disease from primary, secondary, and tertiary hospital in Daegu-Gyeongbuk province of Korea.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
100 Participants
are grouped into 1 trial groupGroup A: inflammatory bowel disease
Trial outcomes
Primary outcomes
1
All newly diagnosed cases
In one year, all inflammatory bowel disease including Crohn's disease and ulcerative colitis which is newly diagnosed in Daegu-Gyeongbuk province of Korea is recorded.
Time frame
one yearSecondary outcomes
1
All operation cases
For one year, all patients who have surgical managements for IBD are counted.
Time frame
one yearOther outcomes
1
All cases of disease relapse
For one year, all patients who have disease worsening are counted.
Time frame
one yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Kyungpook National University Hospital
Lead sponsor
Yeungnam University Hospital
Collaborator
Daegu Catholic University Medical Center
Collaborator
DongGuk University
Collaborator
Source ClinicalTrials.gov